Fundraising FoxPathway to Cures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Spark Biomedicalsparkbiomedical.comin𝕏Mar 2023 · $15M
Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics.
BiotechDigital HealthHardwareHealthtechMedical DevicesDallas, US
Daniel Powell(President & Chief Executive Officer)inAlejandro Covalin(Chief Technology Officer)inNavid Khodaparast(Chief Science Officer)inTed Costopoulos(Director)Carl R. Deeley(Director)
Co-investorsAggie Angel NetworkWave Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.